Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma.
作者： Serena De Luca , Rosa Fonti , Luigi Camera , Barbara Salvatore , Antongiulio Faggiano
DOI: 10.1007/S12149-015-1056-5
关键词:
摘要: Objective The aim of our study was to determine the role fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) and indium-111 Octreotide single photon (111In-Octreotide SPECT) in evaluation metastatic medullary thyroid carcinoma (MMTC).
springer.com
elsevier.com
core.ac.uk 
sci-hub.se 参考文章(37)
Xu Cheng, Lihua Bao, Zhaoqiang Xu, Dianfu Li, Jie Wang, Yongjun Li, ¹⁸F-FDG-PET and ¹⁸F-FDG-PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: a systematic review and meta-analysis. Journal of Medical Imaging and Radiation Oncology. ,vol. 56, pp. 136- 142 ,(2012) , 10.1111/J.1754-9485.2012.02344.X
Jessica E. Maxwell, Scott K. Sherman, Thomas M. O'Dorisio, James R. Howe, Medical management of metastatic medullary thyroid cancer Cancer. ,vol. 120, pp. 3287- 3301 ,(2014) , 10.1002/CNCR.28858
Samuel A. Wells, Sylvia L. Asa, Henning Dralle, Rossella Elisei, Douglas B. Evans, Robert F. Gagel, Nancy Lee, Andreas Machens, Jeffrey F. Moley, Furio Pacini, Friedhelm Raue, Karin Frank-Raue, Bruce Robinson, M. Sara Rosenthal, Massimo Santoro, Martin Schlumberger, Manisha Shah, Steven G. Waguespack, Revised American thyroid association guidelines for the management of medullary thyroid carcinoma Thyroid. ,vol. 25, pp. 567- 610 ,(2015) , 10.1089/THY.2014.0335
Martin Schlumberger, Francesca Carlomagno, Eric Baudin, Jean Michel Bidart, Massimo Santoro, New therapeutic approaches to treat medullary thyroid carcinoma. Nature Clinical Practice Endocrinology & Metabolism. ,vol. 4, pp. 22- 32 ,(2008) , 10.1038/NCPENDMET0717
Alessandro Giordano, Vittoria Rufini, Giorgio Treglia, Maria Felicia Villani, Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 fluorodeoxyglucose positron emission tomography: a meta-analysis. Endocrine. ,vol. 42, pp. 535- 545 ,(2012) , 10.1007/S12020-012-9671-6
Vittoria Rufini, Maria Lucia Calcagni, Richard P Baum, None, Imaging of neuroendocrine tumors. Seminars in Nuclear Medicine. ,vol. 36, pp. 228- 247 ,(2006) , 10.1053/J.SEMNUCLMED.2006.03.007
Evangelia Skoura, Ioannis E. Datseris, Phivi Rondogianni, Stylianos Tsagarakis, Marinella Tzanela, Maria Skilakaki, Dimitrios Exarhos, Maria Alevizaki, Correlation between Calcitonin Levels and [(18)F]FDG-PET/CT in the Detection of Recurrence in Patients with Sporadic and Hereditary Medullary Thyroid Cancer. International Scholarly Research Notices. ,vol. 2012, pp. 375231- 375231 ,(2012) , 10.5402/2012/375231
P. Gómez-Camarero, A. Ortiz-de Tena, I. Borrego-Dorado, R.J. Vázquez-Albertino, E. Navarro-González, J.V. Ruiz-Franco-Baux, J.I. Cuenca-Cuenca, [Evaluation of efficacy and clinical impact of 18F-FDG-PET in the diagnosis of recurrent medullary thyroid cancer with increased calcitonin and negative imaging test]. Revista Espanola De Medicina Nuclear. ,vol. 31, pp. 261- 266 ,(2012) , 10.1016/J.REMNIE.2012.07.012
Dhakshinamoorthy Ganeshan, Erik Paulson, Cihan Duran, Maria E. Cabanillas, Naifa L. Busaidy, Chusilp Charnsangavej, Current update on medullary thyroid carcinoma American Journal of Roentgenology. ,vol. 201, ,(2013) , 10.2214/AJR.12.10370
Sue Chua, Gopinath Gnanasegaran, Gary J.R. Cook, Miscellaneous Cancers (Lung, Thyroid, Renal Cancer, Myeloma, and Neuroendocrine Tumors): Role of SPECT and PET in Imaging Bone Metastases Seminars in Nuclear Medicine. ,vol. 39, pp. 416- 430 ,(2009) , 10.1053/J.SEMNUCLMED.2009.07.002